Antabio Awarded EUR 0.9 million funding from the Occitanie Region to support the Preclinical Development of MEM-ANT3310, Antabio’s Novel Broad-Spectrum Combination Therapy Targeting WHO’s Priority Pathogens

Mar 16, 2021

Une aide de 886 020 euros au titre du Contrat Innovation Région est attribuée pour le développement de ANT3310-MEM, un produit destiné à lutter contre les infections respiratoires acquises à l’hôpital. Labège, France, 16 Mars, 2021. Antabio SAS, société...

Antabio Receives FDA Qualified Infectious Disease Product (QIDP) Designation for MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO’s Priority Pathogens

May 6, 2020

Antabio SAS announced today that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation to Antabio’s MEM-ANT3310, a combination of meropenem (MEM) and the novel broad-spectrum serine beta-lactamase inhibitor...

Antabio Awarded $4.4 Million from CARB-X for the Further Development of its New Treatment for Pseudomonas aeruginosa Infections in Cystic Fibrosis Patients

Jan 2, 2020

The funding will be used to advance Antabio’s Pseudomonas Elastase Inhibitor (PEi) program up to completion of non-GLP preclinical studie Labège, France, 2nd January 2020. Antabio SAS, the biopharmaceutical company focused on developing a broad pipeline of...

Antabio applauds the new mechanism for reimbursement of antibiotics set up by CMS in the US

Aug 7, 2019

On August 2, 2019. The US government announced several significant changes to hospital antibiotic reimbursement by Medicare & Medicaid (CMS) in US hospitals. Importantly, the new Policy defines rules for reimbursing new antibiotics with Qualified Infectious...

Antabio Receives QIDP Designation from the U.S. FDA for the Development of Its Metallo Beta-Lactamase inhibitor ANT2681

Jun 21, 2019

Antabio SAS, a private biopharmaceutical company developing novel antibacterial treatments focused on drug-resistant life-threatening infections, announced today that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP)...